{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:19:36Z","timestamp":1787761176233,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejpb.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T04:20:18Z","timestamp":1687666818000},"page":"202-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-6432","authenticated-orcid":false,"given":"Chun Yuen Jerry","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-5460","authenticated-orcid":false,"given":"Alberto","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hale","family":"Oguzlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xin Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athenea Pascual","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Singhera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thamboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhav","family":"Pratap-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-017X","authenticated-orcid":false,"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.06.015_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-510X(77)90104-6","article-title":"Liposome toxicity in the mouse central nervous system","volume":"31","author":"Adams","year":"1977","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejpb.2023.06.015_b0010","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/molecules25051065","article-title":"Investigation of the absorption of nanosized lamotrigine containing nasal powder via the nasal cavity","volume":"25","author":"Ambrus","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2023.06.015_b0015","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/mp500758s","article-title":"Analysis of the particle formation process of structured microparticles","volume":"12","author":"Baldelli","year":"2015","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.ejpb.2023.06.015_b0020","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.drudis.2022.04.012","article-title":"Engineered nasal dry powder for the encapsulation of bioactive compounds","volume":"27","author":"Baldelli","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2023.06.015_b0025","first-page":"1","article-title":"Spray freeze drying for protein encapsulation: Impact of the formulation to morphology and stability","author":"Baldelli","year":"2022","journal-title":"Drying Technol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0030","article-title":"Effect of the formulation on mucoadhesive spray-dried microparticles containing iron for food fortification","volume":"107906","author":"Baldelli","year":"2022","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ejpb.2023.06.015_b0035","doi-asserted-by":"crossref","first-page":"1209534","DOI":"10.3389\/fddev.2023.1209534","article-title":"Design of respirable sprayed microparticles of encapsulated bacteriophages","volume":"3","author":"Baldelli","year":"2023","journal-title":"Frontiers in Drug Delivery"},{"key":"10.1016\/j.ejpb.2023.06.015_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfoodeng.2022.111191","article-title":"Spray freeze drying of dairy products: Effect of formulation on dispersibility","volume":"335","author":"Baldelli","year":"2022","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ejpb.2023.06.015_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105401","article-title":"Sprayed microcapsules of minerals for fortified food","volume":"101","author":"Baldelli","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ejpb.2023.06.015_b0050","article-title":"On determining soot maturity: A review of the role of microscopy-and spectroscopy-based techniques","volume":"126532","author":"Baldelli","year":"2020","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejpb.2023.06.015_b0055","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/02786826.2016.1216941","article-title":"Control of the radial distribution of chemical components in spray-dried crystalline microparticles","volume":"50","author":"Baldelli","year":"2016","journal-title":"Aerosol Sci. Tech."},{"key":"10.1016\/j.ejpb.2023.06.015_b0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0021-9150(95)05713-7","article-title":"Serum levels of the TGF-beta receptor are increased in atherosclerosis","volume":"120","author":"Blann","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejpb.2023.06.015_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/9781118921265.ch2","article-title":"Lecithins","author":"Bueschelberger","year":"2014","journal-title":"Emulsifiers in Food Technology"},{"key":"10.1016\/j.ejpb.2023.06.015_b0070","first-page":"749","article-title":"Systemic delivery to central nervous system by engineered PLGA nanoparticles","volume":"8","author":"Cai","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejpb.2023.06.015_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.716380","article-title":"Anti-Inflammatory properties of statin-loaded biodegradable lecithin\/chitosan nanoparticles: a step toward nose-to-brain treatment of neurodegenerative diseases","volume":"12","author":"Clementino","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/neuonc\/nou283","article-title":"The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis","volume":"17","author":"de Robles","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2019.01.012","article-title":"In vitro characterization of physico-chemical properties, cytotoxicity, bioactivity of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate nasal powder formulation","volume":"558","author":"Fallacara","year":"2019","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.ejpb.2023.06.015_b0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.06.002","article-title":"PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood\u2013brain barrier","volume":"211","author":"Fornaguera","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.06.015_b0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/17425247.2019.1597051","article-title":"Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders","volume":"16","author":"Gholizadeh","year":"2019","journal-title":"Expert Opin Drug Del"},{"key":"10.1016\/j.ejpb.2023.06.015_b0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/10717544.2018.1428242","article-title":"In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates","volume":"25","author":"Giuliani","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.06.015_b0105","first-page":"1","article-title":"Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques","volume":"12","author":"Guo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2023.06.015_b0110","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s11095-014-1605-y","article-title":"Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler","volume":"32","author":"Haghi","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.06.015_b0115","first-page":"945","article-title":"TGF-\u03b2 signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejpb.2023.06.015_b0120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12249-011-9614-1","article-title":"Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution","volume":"12","author":"Hoekman","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2023.06.015_b0125","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/app.22135","article-title":"Predictors of glass transition in the biodegradable poly-lactide and poly-lactide-co-glycolide polymers","volume":"100","author":"Park","year":"2006","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2023.06.015_b0130","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","article-title":"Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration","volume":"28","author":"Kanazawa","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.06.015_b0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41586-020-2850-3","article-title":"Cancer immunotherapy via targeted TGF-\u03b2 signalling blockade in TH cells","volume":"587","author":"Li","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2023.06.015_b0140","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1039\/C9SM02199J","article-title":"Liquid marbles from soot films","volume":"16","author":"Li","year":"2020","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejpb.2023.06.015_b0145","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jocn.2008.01.003","article-title":"Transforming growth factor-beta (TGF-\u03b2) and brain tumours","volume":"15","author":"Luwor","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ejpb.2023.06.015_b0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.powtec.2012.03.033","article-title":"Particle size, size distribution and morphological evaluation of airborne dust particles of diverse woods by Scanning Electron Microscopy and image processing program","volume":"225","author":"Mazzoli","year":"2012","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/CCO.0b013e32834a6f61","article-title":"Genetic causes of glioma: new leads in the labyrinth","volume":"23","author":"Melin","year":"2011","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.06.015_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01610-7","article-title":"Overcoming the blood\u2013brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches","volume":"20","author":"Mitusova","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0170","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/acs.molpharmaceut.5b00852","article-title":"Primary Air-Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery","volume":"13","author":"Ong","year":"2016","journal-title":"Mol Pharmaceut"},{"key":"10.1016\/j.ejpb.2023.06.015_b0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.06.015_b0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2016.07.010","article-title":"Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products","volume":"107","author":"Pozzoli","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ejpb.2023.06.015_b0185","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2023.06.015_b0190","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2023.06.015_b0195","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/10837450.2021.1888980","article-title":"Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion","volume":"26","author":"Shukr","year":"2021","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2023.06.015_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J Lab Autom"},{"key":"10.1016\/j.ejpb.2023.06.015_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/pt010324","article-title":"Effect of Carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive polyethylene glycol gels","volume":"1","author":"Tan","year":"2000","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2023.06.015_b0210","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12247-015-9222-9","article-title":"Influence of dosage form, formulation, and delivery device on olfactory deposition and clearance: enhancement of nose-to-CNS uptake","volume":"10","author":"Vasa","year":"2015","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2023.06.015_b0215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2023.06.015_b0220","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.drudis.2019.06.001","article-title":"Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges","volume":"24","author":"Vitorino","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2023.06.015_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118720","article-title":"Bio-nanotechnological advancement of orally administered insulin nanoparticles: Comprehensive review of experimental design for physicochemical characterization","volume":"572","author":"Wong","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2023.06.015_b0230","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/pharmaceutics13040500","article-title":"PLGA nanoparticle-based formulations to cross the blood\u2013brain barrier for drug delivery: From R&D to cGMP","volume":"13","author":"Zhi","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:53:37Z","timestamp":1760547217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"alternative-id":["S0939641123001686"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.06.015","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}